In life sciences and healthcare supply chains, every transaction has to be accurate, traceable, and audit-ready. As products move across manufacturing sites, distribution partners, and external organizations, teams rely on systems that keep data aligned, track every change, and ensure work holds up under regulatory scrutiny—so product moves without interruption and every step can be verified during audits.
In this video series, Bob Sturim, SVP of Platform Products and CTO at TraceLink, explains what that requires from an industrial-grade, GxP-compliant network platform. On OPUS (Orchestration Platform for Universal Solutions), companies run supply chain processes on a single, validation-ready foundation that keeps data, workflows, and partner interactions in sync—so teams can execute across partners without introducing risk or inconsistency.
The benefits are clear—teams can trace every transaction end-to-end, complete audits without rework, and resolve issues without chasing data across systems. As AI and agentic capabilities are introduced, they operate within this controlled environment—helping teams act faster while maintaining full oversight and compliance. Watch the full series to see how TraceLink supports regulated, agentic supply chain execution at scale.
Why Do Life Sciences Platforms Need to Be Purpose-Built?
Why Must Life Sciences Platforms Be Built for Reliability?
Why Do Life Sciences CIOs Need a Unified Platform for System Integrity?
How Does TraceLink Architect Its Platform for Network Scale?
Why Is an Industrial-Grade Platform Critical for Accelerating Innovation?
Where Is TraceLink Investing to Expand the Capabilities of OPUS?
How Can CIOs Ensure Compliance Remains Durable as Platforms Evolve?
How Should CIOs Balance AI Agent Autonomy with Human Oversight?
